caplin point labs shares: Fundamental Radar: Why is Caplin Point Labs poised to see a 20% upside?
For Caplin Point, both the US and emerging markets of Latin America and Africa continued to grow, and with a healthy order book and drug approvals, the company hopes to clock revenue growth of 50% for the US markets, which constitute 15% of the total revenue.